LCK and glioblastoma: Although, A7700451 is highly potent inhibitor of Lck activity, it also binds at least 30 more kinases and receptors with high affinity [30], which may contribute to its biological potency against human glioblastoma and explain the extent of transcript inhibition that we observed in vivo.